Company News /
by Adrian Tan -
A month ago
23 Dec 2024 - Some of the companies with the biggest share prices increases over the past year.
Company News /
by Adrian Tan -
A month ago
20 Dec 2024 - Mesoblast (ASX:MSB) has received approval from the US Food and Drug Administration (FDA) for Ryoncil (remestemcel-L), making it the first mesenchymal stromal cell (MS…
Company News /
by Adrian Tan -
A month ago
05 Dec 2024 - The FDA has granted Regenerative Medicine Advanced Therapy designation to Mesoblast's Revascor drug.
Company News /
by Adrian Tan -
2 months ago
31 Oct 2024 - Mesoblast (ASX:MSB; Nasdaq:MESO) has reported significant milestones in its Q1 FY2025 results, including an anticipated FDA decision on its lead product, Ryoncil.
Market Reports /
by Paul Sanger -
2 years ago
08 Aug 2022 - The labour market added 528,000 jobs in July, easily beating a Dow Jones estimate of a 258,000 increase. The unemployment rate ticked down to 3.5 per cent, below the …
Market Reports /
by Paul Sanger -
2 years ago
19 Jul 2022 - The ASX is trading lower this morning with most sectors lower led by tech, down 1.39 per cent. The best-performing sector is Energy, up 2.87 per cent.
Market Reports /
by Melissa Darmawan -
2 years ago
24 Mar 2022 - The Australian sharemarket managed to eke out a gain to post a third straight close ahead of Russia’s stock exchange set to open shortly after a month long shutdown.
Market Reports /
by Melissa Darmawan -
2 years ago
24 Mar 2022 - The ASX has marched higher after a weak start as the local bourse looks to continue its rally for the 6th time in 7-days. Oil prices continue to climb ahead of the NA…
Market Reports /
by Lauren Evans -
2 years ago
09 Mar 2022 - After a strong start, the ASX swam in positive territory for the remainder of Wednesday’s session with all sectors in the green. Technology finished as the best perfo…
Market Reports /
by Lauren Evans -
2 years ago
08 Mar 2022 - After see-saw trading this morning, the ASX fell into negative territory in the afternoon session as investors searched for safety amid the US and allies mulling a ba…
Market Reports /
by Melissa Darmawan -
2 years ago
07 Mar 2022 - Major indexes around the globe closed mixed as traders reacted to Russia's shelling & takeover of Europe’s largest nuclear power plant in Ukraine. Commodity prices co…
Market Reports /
by Melissa Darmawan -
3 years ago
31 Dec 2021 - The ASX took a breather from its 6-day rally as investors were stunned by the hot on the heels record spike in Covid-19 cases across the nation to wrap up 2021. The p…
Company News /
by Melissa Darmawan -
3 years ago
31 Dec 2021 - Mesoblast (ASX:MSB) met with the US FDA watchdog for skin therapies to discuss their letter for a cell treatment to address steroid-refractory acute graft versus host…
Market Reports /
by Melissa Darmawan -
3 years ago
16 Dec 2021 - The Australian sharemarket fell for its third day in a row despite a positive lead from Wall St and stronger than expected jobs numbers for November. Market participa…
Market Reports /
by Lauren Evans -
3 years ago
15 Dec 2021 - The ASX is in negative territory this morning amid another surge in Covid-19 cases. At noon, the S&P/ASX 200 is 0.6% or 43.5 points lower at 7334.9. The SPI futures a…
Market Reports /
by Melissa Darmawan -
3 years ago
15 Dec 2021 - Major indexes around the globe decline ahead of central bank meetings amid US data showing producer price inflation hitting a record high. Citi rated Charter Hall (AS…
Market Reports /
by Lauren Evans -
3 years ago
14 Dec 2021 - The ASX lifted in the afternoon session but remained under pressure as Mesoblast, Woolworths and Afterpay weighed on the market. Amid a surge in Covid-19 cases, the S…
Company News /
by Lauren Evans -
3 years ago
14 Dec 2021 - Pharmaceutical company Novartis has terminated its agreement with medicine developer Mesoblast (ASX:MSB) prior to closing.
